Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease

Neuroscience

Volumn 153, Issue 3, 2008, Pages 618-633

  Giovannini, M G ^a   Cerbai, F ^a   Bellucci, A ^a   Melani, C ^a   Grossi, C ^a   Bartolozzi, C ^a   Nosi, D ^a   Casamenti, F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

cholinergic stimulation; ERK; immunohistochemistry; JNK; p38MAPK

Indexed keywords

ENZYME ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN DYSFUNCTION; BRAIN NERVE CELL; CONTROLLED STUDY; ENZYME ACTIVATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MEMORY DISORDER; MICROGLIA; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WESTERN BLOTTING; WILD TYPE;

EID: 43049118551     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.02.061     Document Type: Article

References (85)

1. M.A. Aberg N.D. Aberg T.D. Palmer A.M. Alborn C. Carlsson-Skwirut P. Bang L.E. Rosengren T. Olsson F.H. Gage P.S. Eriksson IGF-I has a direct proliferative effect in adult hippocampal progenitor cells Mol Cell Neurosci 24 2003 23 40
2. J.P. Adams J.D. Sweatt Molecular psychology: roles for the ERK MAP kinase cascade in memory Annu Rev Pharmacol Toxicol 42 2002 135 163
3. C.M. Atkins J.C. Selcher J.J. Petraitis J.M. Trzaskos J.D. Sweatt The MAPK cascade is required for mammalian associative learning Nat Neurosci 1 1998 602 609
4. C. Atzori B. Ghetti R. Piva A.N. Srinivasan P. Zolo M.B. Delisle S.S. Mirra A. Migheli Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis J Neuropathol Exp Neurol 60 2001 1190 1197
5. R.T. Bartus R.L. Dean B. Beer A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 417
6. A. Bellucci I. Luccarini C. Scali C. Prosperi M.G. Giovannini G. Pepeu F. Casamenti Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice Neurobiol Dis 23 2006 260 272
7. A. Bellucci M.C. Rosi C. Grossi A. Fiorentini I. Luccarini F. Casamenti Abnormal processing of tau in the brain of aged TgCRND8 mice Neurobiol Dis 27 2007 328 338
8. J.L. Berkeley J. Gomeza J. Wess S.E. Hamilton N.M. Nathanson A.I. Levey M1 muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices Mol Cell Neurosci 18 2001 512 524
9. D.E. Berman S. Hazvi K. Rosenblum R. Seger Y. Dudai Specific and differential activation of mitogen-activated protein kinase cascades by unfamiliar taste in the insular cortex of the behaving rat J Neurosci 18 1998 10037 10044
10. S. Blum A.N. Moore F. Adams P.K. Dash A mitogen-activated protein kinase cascade in the CA1/CA2 subfield of the dorsal hippocampus is essential for long-term spatial memory J Neurosci 19 1999 3535 3544
11. L. Bondolfi M. Calhoun F. Ermini H.G. Kuhn K.H. Wiederhold L. Walker M. Staufenbiel M. Jucker Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice J Neurosci 22 2002 515 522
12. D.A. Butterfield D. Boyd-Kimball Amyloid beta-peptide(1–42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain Brain Pathol 14 2004 426 432
13. M.E. Calhoun K.H. Wiederhold D. Abramowski A.L. Phinney A. Probst C. Sturchler-Pierrat M. Staufenbiel B. Sommert M. Jucker Neuron loss in APP transgenic mice Nature 395 1998 755 756
14. M. Cammarota L.R. Bevilaqua P. Ardenghi G. Paratcha D.S. Levi I. Izquierdo J.H. Medina Learning-associated activation of nuclear MAPK, CREB and Elk-1, along with Fos production, in the rat hippocampus after a one-trial avoidance learning: abolition by NMDA receptor blockade Brain Res Mol Brain Res 76 2000 36 46
15. H.J. Chen M. Rojas-Soto A. Oguni M.B. Kennedy A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II Neuron 20 1998 895 904
16. M.A. Chishti D.S. Yang C. Janus A.L. Phinney P. Horne J. Pearson R. Strome N. Zuker J. Loukides J. French S. Turner G. Lozza M. Grilli S. Kunicki C. Morissette J. Paquette F. Gervais C. Bergeron P.E. Fraser G.A. Carlson P.S. George-Hyslop D. Westaway Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 J Biol Chem 276 2001 21562 21570
17. I. Churcher Tau therapeutic strategies for the treatment of Alzheimer's disease Curr Top Med Chem 6 2006 579 595
18. K.C. Corbit D.A. Foster M.R. Rosner Protein kinase Cdelta mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells Mol Cell Biol 19 1999 4209 4218
19. W.M. Daniels J. Hendricks R. Salie J.J. Taljaard The role of the MAP-kinase superfamily in beta-amyloid toxicity Metab Brain Dis 16 2001 175 185
20. K.T. Dineley M. Westerman D. Bui K. Bell K.H. Ashe J.D. Sweatt Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease J Neurosci 21 2001 4125 4133
21. S. Dudal P. Krzywkowski J. Paquette C. Morissette D. Lacombe P. Tremblay F. Gervais Inflammation occurs early during the Abeta deposition process in TgCRND8 mice Neurobiol Aging 25 2004 861 871
22. I. Ferrer R. Blanco M. Carmona B. Puig M. Barrachina C. Gomez S. Ambrosio Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and dementia with Lewy bodies J Neural Transm 108 2001 1383 1396
23. I. Ferrer T. Gomez-Isla B. Puig M. Freixes E. Ribe E. Dalfo J. Avila Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies Curr Alzheimer Res 2 2005 3 18
24. C. Geula C.K. Wu D. Saroff A. Lorenzo M. Yuan B.A. Yankner Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity Nat Med 4 1998 827 831
25. M.G. Giovannini The role of the extracellular signal-regulated kinase pathway in memory encoding Rev Neurosci 17 2006 619 634
26. 2+/calmodulin-dependent protein kinase II in long-term potentiation J Neurosci 21 2001 7053 7062
27. M.G. Giovannini M. Efoudebe M.B. Passani E. Baldi C. Bucherelli F. Giachi R. Corradetti P. Blandina Improvement in fear memory by histamine-elicited ERK2 activation in hippocampal CA3 cells J Neurosci 23 2003 9016 9023
28. M.G. Giovannini C. Scali C. Prosperi A. Bellucci M.G. Vannucchi S. Rosi G. Pepeu F. Casamenti Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway Neurobiol Dis 11 2002 257 274
29. F. Gonzalez-Scarano G. Baltuch Microglia as mediators of inflammatory and degenerative diseases Annu Rev Neurosci 22 1999 219 240
30. J. Gotz F. Chen J. van Dorpe R.M. Nitsch Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils Science 293 2001 1491 1495
31. S.S. Grewal R.D. York P.J. Stork Extracellular-signal-regulated kinase signalling in neurons Curr Opin Neurobiol 9 1999 544 553
32. K.Z. Guyton M. Gorospe T.W. Kensler N.J. Holbrook Mitogen-activated protein kinase (MAPK) activation by butylated hydroxytoluene hydroperoxide: implications for cellular survival and tumor promotion Cancer Res 56 1996 3480 3485
33. J.J. Haddad Mitogen-activated protein kinases and the evolution of Alzheimer's: a revolutionary neurogenetic axis for therapeutic intervention? Prog Neurobiol 73 2004 359 377
34. M.E. Harris K. Hensley D.A. Butterfield R.A. Leedle J.M. Carney Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1–40) in cultured hippocampal neurons Exp Neurol 131 1995 193 202
35. K. Hensley R.A. Floyd N.Y. Zheng R. Nael K.A. Robinson X. Nguyen Q.N. Pye C.A. Stewart J. Geddes W.R. Markesbery E. Patel G.V. Johnson G. Bing p38 Kinase is activated in the Alzheimer's disease brain J Neurochem 72 1999 2053 2058
36. M. Hetman K. Kanning J.E. Cavanaugh Z. Xia Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase J Biol Chem 274 1999 22569 22580
37. K. Hsiao P. Chapman S. Nilsen C. Eckman Y. Harigaya S. Younkin F. Yang G. Cole Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice Science 274 1996 99 106
38. M. Hull K. Lieb B.L. Fiebich Pathways of inflammatory activation in Alzheimer's disease: potential targets for disease modifying drugs Curr Med Chem 9 2002 83 88
39. D.Y. Hwang J.S. Cho S.H. Lee K.R. Chae H.J. Lim S.H. Min S.J. Seo Y.S. Song C.W. Song S.G. Paik Y.Y. Sheen Y.K. Kim Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw Exp Neurol 186 2004 20 32
40. D.Y. Hwang J.S. Cho J.H. Oh S.B. Shim S.W. Jee S.H. Lee S.J. Seo C.W. Song S.H. Lee Y.K. Kim Early changes in behavior deficits, amyloid beta-42 deposits and MAPK activation in doubly transgenic mice co-expressing NSE-controlled human mutant PS2 and APPsw Cell Mol Neurobiol 25 2005 881 898
41. L.A. Hyde T.M. Kazdoba M. Grilli G. Lozza R. Brusa Q. Zhang G.T. Wong M.F. McCool L. Zhang E.M. Parker G.A. Higgins Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice Behav Brain Res 160 2005 344 355
42. 2+ stimulation of CREB-dependent transcription and ERK nuclear translocation Neuron 21 1998 869 883
43. B. Kaminska MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits Biochim Biophys Acta 1754 2005 253 262
44. B. Kaminska L. Kaczmarek S. Zangenehpour A. Chaudhuri Rapid phosphorylation of Elk-1 transcription factor and activation of MAP kinase signal transduction pathways in response to visual stimulation Mol Cell Neurosci 13 1999 405 414
45. R.J. Kelleher III A. Govindarajan H.Y. Jung H. Kang S. Tonegawa Translational control by MAPK signaling in long-term synaptic plasticity and memory Cell 116 2004 467 479
46. T.K. Khan D.L. Alkon An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin Proc Natl Acad Sci U S A 103 2006 13203 13207
47. J.H. Kim D. Liao L.F. Lau R.L. Huganir SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family Neuron 20 1998 683 691
48. J.L. Kummer P.K. Rao K.A. Heidenreich Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase J Biol Chem 272 1997 20490 20494
49. J. Lewis D.W. Dickson W.L. Lin L. Chisholm A. Corral G. Jones S.H. Yen N. Sahara L. Skipper D. Yager C. Eckman J. Hardy M. Hutton E. McGowan Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP Science 293 2001 1487 1491
50. W.R. Markesbery The role of oxidative stress in Alzheimer disease Arch Neurol 56 1999 1449 1452
51. C.J. Marshall Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation Cell 80 1995 179 185
52. E. Masliah A. Sisk M. Mallory L. Mucke D. Schenk D. Games Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease J Neurosci 16 1996 5796 5811
53. M.M. Mesulam E.J. Mufson B.H. Vainer A.I. Levey Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6) Neuroscience 10 1983 1185 1201
54. Y. Morishima Y. Gotoh J. Zieg T. Barrett H. Takano R. Flavell R.J. Davis Y. Shirasaki M.E. Greenberg Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand J Neurosci 21 2001 7551 7560
55. B. Murray A. Alessandrini A.J. Cole A.G. Yee E.J. Furshpan Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity Proc Natl Acad Sci U S A 95 1998 11975 11980
56. S.L. Patterson C. Pittenger A. Morozov K.C. Martin H. Scanlin C. Drake E.R. Kandel Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase Neuron 32 2001 123 140
57. G. Pearson F. Robinson G.T. Beers B.E. Xu M. Karandikar K. Berman M.H. Cobb Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions Endocr Rev 22 2001 153 183
58. G. Pepeu Brain acetylcholine: an inventory of our knowledge on the 50th anniversary of its discovery Trends Pharmacol Sci 4 1983 416 418
59. E.K. Perry B.E. Tomlinson G. Blessed K. Bergman P.H. Gibson R.H. Perry Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia BMJ 2 1978 1457 1459
60. J. Pouyssegur V. Volmat P. Lenormand Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling Biochem Pharmacol 64 2002 755 763
61. M. Raman W. Chen M.H. Cobb Differential regulation and properties of MAPKs Oncogene 26 2007 3100 3112
62. K. Rosenblum M. Futter M. Jones E.C. Hulme T.V. Bliss ERKI/II regulation by the muscarinic acetylcholine receptors in neurons J Neurosci 20 2000 977 985
63. N.J. Rothwell G.N. Luheshi Interleukin 1 in the brain: biology, pathology and therapeutic target Trends Neurosci 23 2000 618 625
64. M. Sarter J.P. Bruno Cognitive functions of cortical acetylcholine: toward a unifying hypothesis Brain Res Brain Res Rev 23 1997 28 46
65. M.J. Savage Y.G. Lin J.R. Ciallella D.G. Flood R.W. Scott Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition J Neurosci 22 2002 3376 3385
66. R. Seger E.G. Krebs The MAPK signaling cascade FASEB J 9 1995 726 735
67. J.C. Selcher C.M. Atkins J.M. Trzaskos R. Paylor J.D. Sweatt A necessity for MAP kinase activation in mammalian spatial learning Learn Mem 6 1999 478 490
68. D.J. Selkoe Translating cell biology into therapeutic advances in Alzheimer's disease Nature 399 1999 A23 A31
69. S. Subramaniam U. Zirrgiebel H.O. Bohlen Und J. Strelau C. Laliberte D.R. Kaplan K. Unsicker ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3 J Cell Biol 165 2004 357 369
70. A. Sun M. Liu X.V. Nguyen G. Bing P38 MAP kinase is activated at early stages in Alzheimer's disease brain Exp Neurol 183 2003 394 405
71. J.E. Swatton L.A. Sellers R.L. Faull A. Holland S. Iritani S. Bahn Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain Eur J Neurosci 19 2004 2711 2719
72. J.D. Sweatt The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory J Neurochem 76 2001 1 10
73. J.D. Sweatt Mitogen-activated protein kinases in synaptic plasticity and memory Curr Opin Neurobiol 14 2004 311 317
74. K. Takeda H. Ichijo Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system Genes Cells 7 2002 1099 1111
75. S. Traverse N. Gomez H. Paterson C. Marshall P. Cohen Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells Comparison of the effects of nerve growth factor and epidermal growth factor Biochem J 288 Pt 2 1992 351 355
76. C.M. Troy S.A. Rabacchi Z. Xu A.C. Maroney T.J. Connors M.L. Shelanski L.A. Greene beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation J Neurochem 77 2001 157 164
77. R. Walz R. Roesler J. Quevedo M.K. Sant'Anna M. Madruga C. Rodrigues C. Gottfried J.H. Medina I. Izquierdo Time-dependent impairment of inhibitory avoidance retention in rats by posttraining infusion of a mitogen-activated protein kinase kinase inhibitor into cortical and limbic structures Neurobiol Learn Mem 73 2000 11 20
78. B. Webster L. Hansen A. Adame L. Crews M. Torrance L. Thal E. Masliah Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease J Neuropathol Exp Neurol 65 2006 142 151
79. P.J. Whitehouse D.L. Price R.G. Struble A.W. Clark J.T. Coyle M.L. Delong Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain Science 215 1982 1237 1239
80. S. Willaime-Morawek K. Brami-Cherrier J. Mariani J. Caboche B. Brugg C-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in ceramide-induced neuronal apoptosis Neuroscience 119 2003 387 397
81. Z. Xia M. Dickens J. Raingeaud R.J. Davis M.E. Greenberg Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 270 1995 1326 1331
82. R.D. York H. Yao T. Dillon C.L. Ellig S.P. Eckert E.W. McCleskey P.J. Stork Rap1 mediates sustained MAP kinase activation induced by nerve growth factor Nature 392 1998 622 626
83. X. Zhu R.J. Castellani A. Takeda A. Nunomura C.S. Atwood G. Perry M.A. Smith Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the “two hit” hypothesis Mech Ageing Dev 123 2001 39 46
84. X. Zhu A.K. Raina C.A. Rottkamp G. Aliev G. Perry H. Boux M.A. Smith Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease J Neurochem 76 2001 435 441
85. X. Zhu C.A. Rottkamp H. Boux A. Takeda G. Perry M.A. Smith Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease J Neuropathol Exp Neurol 59 2000 880 888